News IntegraGen

Stocks

ALINT

FR0010908723

Biotechnology & Medical Research

Real-time Euronext Paris 11:55:00 2026-11-02 EST			5-day change	1st Jan Change
0.0750 ^EUR	0.00%		-26.47%	-43.61%

10-29	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-12	ABL Texcell Diagnostics to Acquire French Biotech Company IntegraGen	MT

All News

Mentions Relevance

10-29	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-11	ABL Diagnostics Société anonyme completed the acquisition of Business operations and assets of IntegraGen SA for ?0.1 million.	CI
10-06	Verdict on October 9 on IntegraGen's future
09-11	ABL Diagnostics Société anonyme proposed to acquire Business operations and assets of IntegraGen SA.	CI
06-16	IntegraGen Enters Receivership Proceedings
05-28	IntegraGen to file for court-ordered receivership
04-23	IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
25-10-30	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-07-02	IntegraGen SA Not Maintains Revenue Guidance for the Full Year of 2025	CI
25-07-02	IntegraGen SA Reports Sales Results for the First Half of 2025	CI
25-07-02	IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position of €2.1 Million	PU
25-07-02	IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position of €2.1 Million	BU
25-04-29	IntegraGen: 2024 Annual Results	BU
25-04-29	IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-01-15	IntegraGen : Inside Information / Information on annual revenues	PU
25-01-15	IntegraGen SA Announces Unaudited Revenue Results for the Year 2024	CI
25-01-15	IntegraGen: 2024 Revenues of €8.5m, Down 27% Compared With 2023 (+5% Excluding SeqOIA), and Cash Position of €1.9m	BU
24-10-18	IntegraGen: losses reduced, share price soars
24-10-17	IntegraGen: 2024 Half-Year Results - Sales up 6% on a Like-for-Like Basis (Excluding SeqOIA) and Profitability Maintained	BU
24-07-29	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-24	IntegraGen : reports €4.5m in revenues for H1 2024 representing 6% increase compared to H1 2023 and a cash position of €2.8m	PU
24-07-18	IntegraGen Reports Sales Results for the First-Half of 2024	CI
24-07-18	IntegraGen: First-Half 2024 Sales of €4.5m, up 6% on the Scope Excluding SeqOIA and Cash Position of €2.8m	BU
24-04-30	IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-04-18	IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control	BU